Atlas Trials

A Phase I Study of Episcleral Dexamethasone for Treatment of Macular Edema

Clinical trial NCT04005430 · UNKNOWN

Trial details

NCT number
NCT04005430
Sponsor
Targeted Therapy Technologies, LLC
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Refractory Diabetic Macular Edema
Start date
2019-04-03
Primary completion
2024-09-30
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.